EAP Obe-cel (AUTO1-OS1): Expanded Access Program (EAP) for Obecabtagene Autoleucel (obe-cel) Out-of-specification (OOS) in Adult Patients with Acute Lymphoblastic Leukemia

Objective

Clinical Trial Details

Principal Investigator(s)
Waqas Jehangir, MD

Clinical Trial Categories

  • Cancer
  • Leukemia
Contact
Hematology Research Coordinators at 605-322-3090
or hematologyresearch@avera.org

Location

  • Avera Cancer Institute — Sioux Falls
    1000 E 23rd St
    Suite 340
    Sioux Falls, SD 57105
    Main: 605-322-3000